Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Intraocular Lymphoma × Dasatinib × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14 Breast Neoplasms 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Leukemia 11 Leukemia, Myeloid, Chronic-Phase 10 Prostatic Neoplasms 8 Recurrence 6 Lung Neoplasms 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Carcinoma, Non-Small-Cell Lung 6 Neoplasm Metastasis 5 Burkitt Lymphoma 5 Melanoma 4 Glioblastoma 4 Squamous Cell Carcinoma of Head and Neck 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Neoplasms 3 Leukemia, Myeloid, Acute 3 Gliosarcoma 3 Blast Crisis 3 Sarcoma 2 Salivary Gland Neoplasms 2 Rhabdomyosarcoma 2 Rectal Neoplasms 2 Polycythemia Vera 2 Oligodendroglioma 2 Multiple Myeloma 2 Lymphoma 2 Leukemia, Myelomonocytic, Chronic 2

Interventions

Rituximab 7 Peripheral Blood Stem Cell Transplantation 6 fludarabine phosphate 5 Whole-Body Irradiation 5 Cyclophosphamide 5 Etoposide 4 Cyclosporine 4 Tacrolimus 3 Mycophenolic Acid 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Carboplatin 3 Lenalidomide 2 Dexamethasone 2 Calcium Dobesilate 2 Busulfan 2 Antilymphocyte Serum 2 sodium thiosulfate 1 pegfilgrastim 1 oblimersen 1 merphos 1 etoposide phosphate 1 Vorinostat 1 Vincristine 1 Transplantation 1 Thiotepa 1 Therapeutics 1 Sirolimus 1 Radiotherapy 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡